William Castell this week was named vice chairman of the board of directors for General Electric, completing the terms of the acquisition of Amersham by GE. Castell, Amersham’s CEO, is president and chief executive officer of GE Healthcare, the entity that combines Amersham into GE.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In its survey of US adults, the Pew Research Center finds that views on the genetic engineering of animals depend on why it's done.

York University researchers find genomic evidence of inbreeding in the yellow-banded bumblebee, according to Reuters.

The Scientist reports agricultural researchers are working on a gene-stacking tool.

In Nature this week: statistical method for overcoming case-control imbalance issues, and more.